This author has not written his bio yet.
But we are proud to say that Melanie Piontek contributed 42 entries already.
ARTES Biotechnology, specialized in microbial cell line and process development for the pharmaceutical industry recently expanded its service portfolio and supplied samples for preclinical testing to a first client. “With the new equipped pilot plant for production of nonGMP material, we are now in the position to provide our clients with high quality preclinical test […]
ARTES Biotechnology, specialized in recombinant protein production, process and vaccine development from microbial expression systems announces a collaboration with the global pharmaceutical company Boehringer Ingelheim Animal Health. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ […]
